Cosmo Pharmaceuticals N.V. / Key word(s): Study results18-March-2022 / 06:01 GMT/BSTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Dublin, Ireland - 18 March 2022: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) ('Cosmo') announced tha...
United States Falk Gmbh Ucerisr Cortiment Hazel Winchester Cosmo Pharmaceuticalsnv Key Cosmo Pharmaceuticals
Source: pharmiweb.com